• 1. Evidence-Based Medicine Center of Lanzhou University, Basic Science School of Lanzhou University, Lanzhou 730000, China; 2. The First Medical College of Lanzhou University, Lanzhou 730000, China; 3.The Second Medical College of Lanzhou University, Lanzhou 730000,China;
Export PDF Favorites Scan Get Citation

Objective  To systematically evaluate the clinical effectiveness of right ventricular outflow tract (RVOT) pacing for heart disease.
Methods  We searched the electronic bibliographic databases, including The Cochrane Library, PubMed, EMbase, CBM, VIP, CNKI, and WANFANG database to assemble the randomized controlled trials (RCTs) of RVS Pacing compared with right ventricular apical (RVA) pacing for heart disease. The deadline of the retrieval time was January 2010. Data were extracted and evaluated by two reviewers independently with a designed extraction form. The RevMan 5.0 software was used for meta-analysis.
Results  A total of 16 RCTs involving 926 patients were included. The results of meta-analyses showed that right ventricular outflow tract (RVOT) pacing significantly increased the left ventricular ejection fraction of 3 months and 18 months (WMD= 3.53, 95%CI 1.02 to 6.04; WMD= 8.94, 95%CI 7.35 to 10.52).Compared with RVA pacing, RVOT pacing could significantly reduce the QRS wave duration (WMD= –22.42, 95%CI –31.05 to – 13.80) immediately after the operation.
Conclusion  RVOT pacing can give patients a good physiological state which is more consistent with biventricular electric conduction and lead to the hemodynamic improvement in the short term, but the long-term result is not confident.

Citation: ZHANG Yulong,PAN Hui,MA Bin,GUO Jiwu,LI Jiang,YANG Kehu. Right Ventricular Outflow Tract Pacing for Heart Function: A Meta-analysis. Chinese Journal of Evidence-Based Medicine, 2010, 10(4): 476-482. doi: 10.7507/1672-2531.20100431 Copy

  • Previous Article

    Intermittent Pneumatic Compression for Deep Venous Thrombosis Prevention after Major Orthopedic Operation: A Systematic Review
  • Next Article

    Quality Analysis of Clinical Trials on Butylphthalide for Cerebral Ischemic Stroke